AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Cell Source, Inc.

$0.52 +$0.02 (+4.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.5
Day Range
$0.52 - $0.52
Year Range
$0.25$2.25
Market Cap
35.33M
AVG Volume
3.43K
Trailing/Forward PE
-5.2/-
PEG ratio
-0.97
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Net Income (USD) · TTM
-6M-4M-2M022 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
CLCS Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
24 Q4-4.77M
24 Q3-5.23M
24 Q2-5.15M
24 Q1-4.91M
23 Q4-5.32M
23 Q3-5.61M
23 Q2-5.52M
23 Q1-5.51M
22 Q4-5.11M
22 Q3-4.61M
Operating Income (USD) · TTM
-6M-4M-2M022 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
CLCS Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
24 Q4-3.85M
24 Q3-4.17M
24 Q2-4.34M
24 Q1-4.05M
23 Q4-4.33M
23 Q3-4.39M
23 Q2-4.41M
23 Q1-4.54M
22 Q4-4.18M
22 Q3-3.69M
EBITDA (USD) · TTM
-6M-4M-2M022 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
CLCS EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
24 Q4-3.48M
24 Q3-4.11M
24 Q2-3.3M
24 Q1-2.13M
23 Q4-2.41M
23 Q3-1.42M
23 Q2-1.42M
23 Q1-1.42M
22 Q40
22 Q3-93.22K
Cash Flows (USD) · TTM
-4M-3M-2M-1M022 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
CLCS Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
24 Q4-2.68M
24 Q3-2.66M
24 Q2-2.3M
24 Q1-2.21M
23 Q4-2.35M
23 Q3-2.35M
23 Q2-3.16M
23 Q1-2.42M
22 Q4-3.14M
22 Q3-2.87M
EPS (USD) · TTM
-0.2-0.15-0.1-0.05-022 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
CLCS EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
24 Q4-0.15
24 Q3-0.16
24 Q2-0.15
24 Q1-0.15
23 Q4-0.16
23 Q3-0.17
23 Q2-0.17
23 Q1-0.16
22 Q4-0.15
22 Q3-0.13
Expenses (USD) · TTM
-2M02M4M6MR&DSG&ACapex22 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
CLCS Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
24 Q43.85M
24 Q34.03M
24 Q24.19M
24 Q13.91M
23 Q44.18M
23 Q34.39M
23 Q24.41M
23 Q14.54M
22 Q44.18M
22 Q33.69M
Shares Outstanding (USD) · TTM
-1M-750K-500K-250K0Buybacks (Repurchases)Stock-Based Compensation22 Q322 Q423 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
CLCS Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
24 Q4-15.93K
24 Q3-77.17K
24 Q2-891.67K
24 Q1-926.45K
23 Q4-966.46K
23 Q3-924.19K
23 Q2-451.87K
23 Q1-401.83K
22 Q4-77.89K
22 Q3-74.92K
Employee Count
00.511.52201320142015201720182019202020222024
CLCS Employee Count by quarter
PeriodEmployee Count
20241
20221
20201
20191
20181
20171
20151
20141
20131
Free Cash Flow Yield
-30%-25%-20%-15%-10%-5%med -12.61%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CLCS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-11.46%
Sep 26-11.53%
Aug 26-10.29%
Aug 26-10.25%
Aug 26-9.93%
Aug 26-7.24%
Jul 26-6.7%
Jul 26-9.17%
Jul 26-6.93%
Jul 26-6.27%
Jul 26-6.41%
Jun 26-7.27%
Jun 26-7.62%
Jun 26-7.27%
Jun 26-7.27%
May 26-7.45%
May 26-7.27%
May 26-7.27%
May 26-7.09%
May 26-7.09%
Apr 26-7.09%
Apr 26-6.41%
Apr 26-7.12%
Apr 26-7.45%
Mar 26-8.31%
Mar 26-7.74%
Mar 26-6.08%
Mar 26-6.02%
Feb 26-6.21%
Feb 26-7.01%
Feb 26-7.01%
Feb 26-6.62%
Jan 26-6.7%
Jan 26-6.62%
Jan 26-7.12%
Jan 26-8.76%
Jan 26-11.92%
Dec 25-11.92%
Dec 25-11.92%
Dec 25-13.24%
Dec 25-15.68%
Nov 25-15.68%
Nov 25-16.55%
Nov 25-18.06%
Nov 25-15.28%
Oct 25-15.48%
Oct 25-15.89%
Oct 25-14.9%
Oct 25-14.19%
Oct 25-17.03%
Sep 25-14.26%
Sep 25-13.54%
Sep 25-12.68%
Sep 25-14.54%
Aug 25-14.54%
Aug 25-14.54%
Aug 25-16.98%
Aug 25-17.03%
Aug 25-14.9%
Jul 25-14.9%
Jul 25-17.03%
Jul 25-19.16%
Jul 25-21.04%
Jun 25-18.65%
Jun 25-22.07%
Jun 25-20.02%
Jun 25-17.9%
May 25-24.83%
May 25-21.36%
May 25-24.06%
May 25-19.24%
May 25-19.13%
Apr 25-21.68%
Apr 25-21.67%
Apr 25-21.28%
Apr 25-16.56%
Mar 25-19.59%
Mar 25-25.07%
Mar 25-20.89%
Mar 25-17.88%
Feb 25-21.24%
Feb 25-15.66%
Feb 25-11.39%
Feb 25-12.29%
Jan 25-20.21%
Jan 25-17.9%
Jan 25-19.58%
Jan 25-16.74%
Jan 25-15.47%
Dec 24-13.05%
Dec 24-12.53%
Dec 24-10.44%
Dec 24-9.21%
Nov 24-10.44%
Nov 24-10.94%
Nov 24-9.71%
Nov 24-9.16%
Nov 24-8.12%
Oct 24-12.46%
Oct 24-18.68%
EV/EBITDA
00000med 0Sep 18Jan 19Mar 19Jun 19Sep 19Jan 20Mar 20
CLCS EV/EBITDA by quarter
PeriodEV/EBITDA
Mar 200
Mar 200
Mar 200
Mar 200
Feb 200
Feb 200
Feb 200
Feb 200
Jan 200
Jan 200
Jan 200
Jan 200
Jan 200
Dec 190
Dec 190
Dec 190
Nov 190
Nov 190
Nov 190
Oct 190
Oct 190
Oct 190
Oct 190
Sep 190
Sep 190
Sep 190
Aug 190
Aug 190
Aug 190
Aug 190
Aug 190
Jul 190
Jul 190
Jul 190
Jul 190
Jun 190
Jun 190
Jun 190
Jun 190
May 190
May 190
May 190
May 190
May 190
Apr 190
Apr 190
Apr 190
Apr 190
Mar 190
Mar 190
Mar 190
Mar 190
Mar 190
Feb 190
Feb 190
Feb 190
Feb 190
Jan 190
Jan 190
Jan 190
Jan 190
Dec 180
Dec 180
Dec 180
Nov 180
Nov 180
Nov 180
Oct 180
Oct 180
Sep 180
Sep 180
Sep 180
Sep 180
Aug 180
Aug 180
Aug 180
Aug 180
Aug 180
Jul 180
Cell Source, Inc.
CLCS
Stockpicker

Video analysis: CLCS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.